Cargando…

Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence

PURPOSE: To evaluate the effectiveness and acceptability of a 6-week acceptance and commitment therapy (ACT)–based group programme on participants’ fear of cancer recurrence (FCR), quality of life (QoL), psychological distress and psychological flexibility at the end of the programme and 12-week fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinclair, Fiona, Gillanders, David, Rooney, Natalie, Bonathan, Christine, Hendry, Kirsty, McLoone, Philip, Hewitt, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651702/
https://www.ncbi.nlm.nih.gov/pubmed/37966674
http://dx.doi.org/10.1007/s00520-023-08179-3
_version_ 1785147635657605120
author Sinclair, Fiona
Gillanders, David
Rooney, Natalie
Bonathan, Christine
Hendry, Kirsty
McLoone, Philip
Hewitt, Christopher
author_facet Sinclair, Fiona
Gillanders, David
Rooney, Natalie
Bonathan, Christine
Hendry, Kirsty
McLoone, Philip
Hewitt, Christopher
author_sort Sinclair, Fiona
collection PubMed
description PURPOSE: To evaluate the effectiveness and acceptability of a 6-week acceptance and commitment therapy (ACT)–based group programme on participants’ fear of cancer recurrence (FCR), quality of life (QoL), psychological distress and psychological flexibility at the end of the programme and 12-week follow-up. METHODS: A one-group, post-test service evaluation of a real-world psychological programme was carried out to evaluate collected outcome measures and attendance for a total of 21 groups facilitated between 2017 and 2019. Participants were breast cancer survivors who attended a 6-week group programme led by NHS clinicians. Descriptive statistics and repeated measures ANOVA analyses were carried out for each outcome measure. Attendance levels were examined to assess acceptability. RESULTS: A total of 97 group participants who had completed curative treatment for breast cancer took part. Of whom, 89% completed at least 4 of the 6 weekly group sessions and 76% attended the 12-week follow-up session. Eighty-four (87%) participants returned outcome measures at all three time points relative to group participation (T1 = pre, T2 = post T3 = 12-week follow-up). Group participants were female, mean age 51.9 years. FCR was highest at T1 (mean 25.2, SD 4.7), reduced T2 (mean 21.2, SD 5.4) and further lowered T3 (mean 19.5, SD 6.2). This difference was statistically significant (p < 0.001). QoL was lowest at T1 (mean 62.4, SD 15.7), increased T2 (mean 71.7, SD 18.1) and further increased at T3 (mean 75.9, SD 17.5). This difference was statistically significant (p < 0.001). Psychological distress measures were shown to reduce, and psychological flexibility increased. CONCLUSIONS: This real-world evaluation of an ACT-based group programme led to improvements in FCR, QoL, psychological distress and psychological flexibility in this population. This evaluation provides basis for further investigation to determine if these results can be replicated by controlled research design across diverse populations.
format Online
Article
Text
id pubmed-10651702
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106517022023-11-15 Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence Sinclair, Fiona Gillanders, David Rooney, Natalie Bonathan, Christine Hendry, Kirsty McLoone, Philip Hewitt, Christopher Support Care Cancer Research PURPOSE: To evaluate the effectiveness and acceptability of a 6-week acceptance and commitment therapy (ACT)–based group programme on participants’ fear of cancer recurrence (FCR), quality of life (QoL), psychological distress and psychological flexibility at the end of the programme and 12-week follow-up. METHODS: A one-group, post-test service evaluation of a real-world psychological programme was carried out to evaluate collected outcome measures and attendance for a total of 21 groups facilitated between 2017 and 2019. Participants were breast cancer survivors who attended a 6-week group programme led by NHS clinicians. Descriptive statistics and repeated measures ANOVA analyses were carried out for each outcome measure. Attendance levels were examined to assess acceptability. RESULTS: A total of 97 group participants who had completed curative treatment for breast cancer took part. Of whom, 89% completed at least 4 of the 6 weekly group sessions and 76% attended the 12-week follow-up session. Eighty-four (87%) participants returned outcome measures at all three time points relative to group participation (T1 = pre, T2 = post T3 = 12-week follow-up). Group participants were female, mean age 51.9 years. FCR was highest at T1 (mean 25.2, SD 4.7), reduced T2 (mean 21.2, SD 5.4) and further lowered T3 (mean 19.5, SD 6.2). This difference was statistically significant (p < 0.001). QoL was lowest at T1 (mean 62.4, SD 15.7), increased T2 (mean 71.7, SD 18.1) and further increased at T3 (mean 75.9, SD 17.5). This difference was statistically significant (p < 0.001). Psychological distress measures were shown to reduce, and psychological flexibility increased. CONCLUSIONS: This real-world evaluation of an ACT-based group programme led to improvements in FCR, QoL, psychological distress and psychological flexibility in this population. This evaluation provides basis for further investigation to determine if these results can be replicated by controlled research design across diverse populations. Springer Berlin Heidelberg 2023-11-15 2023 /pmc/articles/PMC10651702/ /pubmed/37966674 http://dx.doi.org/10.1007/s00520-023-08179-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Sinclair, Fiona
Gillanders, David
Rooney, Natalie
Bonathan, Christine
Hendry, Kirsty
McLoone, Philip
Hewitt, Christopher
Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
title Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
title_full Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
title_fullStr Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
title_full_unstemmed Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
title_short Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
title_sort real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651702/
https://www.ncbi.nlm.nih.gov/pubmed/37966674
http://dx.doi.org/10.1007/s00520-023-08179-3
work_keys_str_mv AT sinclairfiona realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence
AT gillandersdavid realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence
AT rooneynatalie realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence
AT bonathanchristine realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence
AT hendrykirsty realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence
AT mcloonephilip realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence
AT hewittchristopher realworldevaluationofanacceptanceandcommitmenttherapybasedgroupprogrammeforbreastcancersurvivorswithfearofcancerrecurrence